Numinus wellness inc

Search Search for:. CAN US. Book A call

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets.

Numinus wellness inc

Numinus Wellness Inc. The capital raise is another important step for the mental health care company, which focuses on developing psychedelic-assisted therapies. The financing round also saw contributions from venture fund Integrated V. We see Numinus as playing a critical role in ensuring that therapists have the option to volunteer for experiential training to become fully trained on the latest medicines and their therapeutic methodologies. Scheduled to close around Feb. According to the Numinus, the proceeds from the offering are intended for working capital and general corporate purposes. Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. Post Comment. Sign up. The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. All rights reserved.

He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News.

.

In connection with the Offering, Numinus has secured a lead order from Integrated V. For more than half a century, therapists have expressed a desire to have the opportunity for their own psychedelic experiences as part of their training to feel better prepared to use these medicines to treat their patients. Given the potential demand for novel psychedelic-assisted therapy treatments, there will be a critical need for trained professionals to administer care. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the Act and may not be offered or sold in the United States or to, or for the account or benefit of, U. Numinus intends to use the proceeds of the Offering for working capital and general corporate purposes. Numinus Wellness Inc.

Numinus wellness inc

Each Unit consists of one common share in the capital of Numinus each, a " Common Share " and one Common Share purchase warrant of Numinus each, a " Warrant ". As the new drug application for MDMA was recently accepted by the United States Food and Drug Administration, our clinical research team is continuing to work with exciting new drugs and treatments and our training platform is helping to address the critical need for practitioners to provide psychedelic-assisted therapy," said Payton Nyquvest , Numinus' Founder and CEO. This, along with Dr. Rick Doblin , the Founder and President of the Multidisciplinary Association for Psychedelic Studies, joining us as an unpaid, non-exclusive strategic adviser, bolsters our efforts to provide much-needed transformative care. Rick Doblin stated: "Numinus is making important strides in the mental health field with its strategic focus and thoughtful positioning. Their approach, particularly through the proposed clinical trial for experiential training, is well-designed to equip therapists with the depth of understanding needed to effectively support individuals dealing with trauma. Dane Stevens , co-founder of Optimi Health Corp, a holder of a Health Canada Dealers License, which participated in the Offering and is committed to support Numinus' future initiatives said: "We are proud to support Numinus in their strategic endeavours to ultimately expanding access to psychedelic assisted therapy. Supporting the work they are doing in their industry-leading clinics and their training efforts is an important step towards ensuring access.

Cheap hotels near calicut bus stand

According to the Numinus, the proceeds from the offering are intended for working capital and general corporate purposes. All content on FT. Any information that you receive via FT. Scheduled to close around Feb. Average volume Braxia Scientific cash dwindles even as revenues rise. Adam Jackson writes about the cannabis industry for the Green Market Report. Sign up. Show more US link US. Search the FT Search. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.

Search Search for:. CAN US.

This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities. Looking to become a certified psychedelic Therapist? Montreal Client. Psychedelics is an umbrella term for certain types of drugs that are known for their psychoactive effects, and increasingly for their vast therapeutic potential. Numinus Wellness Inc. We see Numinus as playing a critical role in ensuring that therapists have the option to volunteer for experiential training to become fully trained on the latest medicines and their therapeutic methodologies. Sign up. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. Show more Markets link Markets. Health Care Medical Equipment and Services. Make up to three selections, then save. They include certain types of plants and fungi, as well as synthetic compounds. Actions Add to watchlist Add to portfolio Add an alert.